[EN] PROCESS AND COMPOUNDS FOR THE MANUFACTURE OF OSELTAMIVIR AND ANALOGS THEREOF, AND NEW ANTIVIRAL AGENTS [FR] PROCÉDÉ ET COMPOSÉS POUR LA FABRICATION D'OSELTAMIVIR ET DE SES ANALOGUES, ET NOUVEAUX AGENTS ANTIVIRAUX
[EN] PROCESS AND COMPOUNDS FOR THE MANUFACTURE OF OSELTAMIVIR AND ANALOGS THEREOF, AND NEW ANTIVIRAL AGENTS [FR] PROCÉDÉ ET COMPOSÉS POUR LA FABRICATION D'OSELTAMIVIR ET DE SES ANALOGUES, ET NOUVEAUX AGENTS ANTIVIRAUX
Several Generations of Chemoenzymatic Synthesis of Oseltamivir (Tamiflu): Evolution of Strategy, Quest for a Process-Quality Synthesis, and Evaluation of Efficiency Metrics
作者:Lukas Werner、Ales Machara、Bradford Sullivan、Ignacio Carrera、Michael Moser、David R. Adams、Tomas Hudlicky、John Andraos
DOI:10.1021/jo2018872
日期:2011.12.16
Four generations of chemoenzymatic approaches to oseltamivir are presented. The first two generations relied on the use of cyclohexadiene-cis-diol derived enzymatically from bromobenzene. The third and fourth generation used the corresponding diol obtained fromethylbenzoate by fermentation with E. coli JM109(pDTG601a). Oseltamivir was obtained fromethylbenzoate by intersecting intermediate 39 (third-generation
Short Chemoenzymatic Azide-Free Synthesis of Oseltamivir (Tamiflu): Approaching the Potential for Process Efficiency
作者:Lukas Werner、Ales Machara、Tomas Hudlicky
DOI:10.1002/adsc.200900844
日期:2010.1.4
A shortchemoenzymatic and azide‐free synthesis of oseltamivir was attained with the key steps consisting of a one‐pot Dauben–Michno oxidative transposition and amination and a reductive transposition of an acrylate.
PROCESS AND COMPOUNDS FOR THE MANUFACTURE OF OSELTAMIVIR AND ANALOGS THEREOF, AND NEW ANTIVIRAL AGENTS
申请人:Hudlicky Tomas
公开号:US20120252890A1
公开(公告)日:2012-10-04
The present application relates to processes for the preparation of intermediates useful in the manufacture of oseltamivir and the H
3
PO
4
salt of oseltamivir, Tamiflu®. The application further relates to novel intermediate and compounds and oseltamivir analogs and to pharmaceutical compositions comprising said analog compounds. The application further relates to a method of using the novel analogs of oseltamivir to treat or prevent influenza.